Correction to “Programmed Death Ligand 1 Regulates Epithelial–Mesenchymal Transition and Cancer Stem Cell Phenotypes in Hepatocellular Carcinoma Through the Serum and Glucocorticoid Kinase 2/β‐Catenin Signaling Pathway”

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsWnt/β-catenin signaling in development and cancer · Cancer Cells and Metastasis · Cancer Mechanisms and Therapy
Kong X, Peng H, Liu P, Fu X, Wang N, Zhang D. Programmed death ligand 1 regulates epithelial–mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β‐catenin signaling pathway. Cancer Sci. 2023; 114: 2265–2276. https://doi.org/10.1111/cas.15753
In the above article, the MHCC97H siRNA‐con image in Figure 4D was incorrect. The correct image for Figure 4 is shown below
We apologize for this error.
